Drug discovery software cost and what computer aided drug design and cheminformatics software actually charge

When a vendor publishes nothing, read the public record instead

There is a second source of real prices in this market and almost nobody uses it. US federal contract awards are public, and government laboratories buy the same commercial software a biotech does. That turns a category where every vendor says "contact us" into one where you can read what an agency actually paid, on what term, and sometimes for how many license tokens.

It works best where the contract description is specific. Awards to Chemical Computing Group frequently name the token count, which makes a genuine per token per year figure of roughly $7,250 to $11,070 recoverable from the record: the full workings are on MOE software price. Schrodinger's small molecule suite renewals sit near $198,000 to $209,000 a year in the same record. Discovery Studio base licenses land closer to $29,000 to $41,000, with modules and site licenses stretching far above that, as set out in BIOVIA Discovery Studio price.

OpenEye is the vendor with the longest paper trail. Its one year application packages at NIH run $39,500 to $90,000, one NIH group renewed the same license six Septembers in a row, and toolkit maintenance for the programming libraries runs far higher than either, all laid out in OpenEye Scientific Software price. Workflow platforms price differently again: a Pipeline Pilot deployment is a server, clients and a set of licensed collections, and the awards in Pipeline Pilot pricing run from about $15,600 for one collection to about $200,000 for a multi year deployment.

Property prediction and cheminformatics infrastructure sit lower. Simulations Plus has never published a price for ADMET Predictor, yet five year terms at FDA and CDC work out to about $19,400 to $20,000 a year per seat, as shown in ADMET Predictor price. Chemaxon's JChem, Marvin and Instant JChem are cheaper again per user: a 100 user EPA bundle runs about $26,000 a year, with the rest of the record in Chemaxon pricing.

PBPK and exposure modeling is the priciest corner of the category and the two platforms in it both quote on request. A GastroPlus platform license covering GastroPlus and DDDPlus took effect in September 2026 at $79,812 for twelve months, and the five year FDA term it replaced averaged near $75,200 a year across three products, with the single user rate closer to $19,400: the awards are in GastroPlus price. Certara's Simcyp spans a wider range than any other product here, from a $10,500 annual node license to an institutional agreement near $159,100 a year, and the FDA renewed it at exactly $65,000 three years running, as set out in Simcyp Simulator price. Both model where a compound goes rather than what it inhibits, which is a different purchase from potency.

Pharmacokinetic analysis and population modeling sit one step further along. A single Phoenix WinNonlin named user seat cost $5,870 a year in 2016 and works out near $8,778 per seat on a 2024 award, while the FDA's current Phoenix agreement averages about $166,500 a year, all in Phoenix WinNonlin price. ICON's NONMEM is the cheapest license in this whole record to hold steady: the FDA paid exactly $10,000 a year for seven straight annual awards, then $10,900, as shown in NONMEM license cost.

Structure data and field based design close the list. The Cambridge Structural Database is sold in suites, and four government labs paid the same $15,000 a year for a CSD-Enterprise campus or site license from 2022 to 2024, then $15,418 and $15,727, as set out in Cambridge Structural Database price. Cresset's Flare runs from a five user Flare Designer group at $15,575 a year to a $162,948 Flare FEP bundle on ten GPUs, in Cresset Flare pricing.

Screening data and safety prediction sit on either side of the plate. The Army held a Genedata Screener subscription at $73,700 a year, then $77,000 and $85,340, before a three year license at about $110,080 a year, all set out in Genedata Screener price. Lhasa's Derek Nexus cost the EPA $5,254 to $6,199 a year for one site and five users, and Derek, Meteor and Sarah together $14,651 for the year from August 2025, in Derek Nexus pricing. The other two ICH M7 tools on most shortlists are on the record as well: the NIH held the Leadscope product suite at $27,450 a year for nine years, in Leadscope pricing, and the FDA has paid $15,000 a year for CASE Ultra and META Ultra since 2020, in MultiCASE CASE Ultra pricing.

Use these figures the way a procurement officer would rather than the way a press release would. They are government prices under government catalog codes, so they are a floor for commercial work, not a forecast. Award values sometimes span option years. And a license bought without scientific support is a different product from one bought with it. Read the term and the description, not just the number.